|
[QUOTE=spence;889454]I don't think the government should set prices arbitrarily but can see scenarios where regulations impacting price could be justified.
Take Canada for instance, they have price controls and as a result cheaper drugs. They also have a government system that provides healthcare for everyone, which creates almost a guaranteed customer base. So in this case the price control is balanced (to some degree) with a sure customer. Without price controls they'd risk having to ration some drugs if the manufactures decided to price them above value.
_[QUOTE]
Spence, I would love to see Canada's national formulary. Guarantee it is limited
to one drug per class which means you won't have a choice when it comes
to efficacy or side effect profile. For instance there are many statin drugs
on the market for lowering cholesterol. They are all variations of statins
but each works a little differently. When there is only one,that will be based on the cheapest, and you can't tolerate it or it's not efficacious for you, too bad.
That is One of the biggest problems with government health care, no choice AND
mediocore medicine.
Rationing drugs based on age becomes another problem as expensive chemo
drugs etc. will be too costly to add another 5 years to say maybe a 75 yr old.
Good point on killing the Golden Goose. It is already happening. Companies
will not go out on a limb in R+D if they find a compound that has a limited
use. For instance, Amphotericin B was developed years ago to treat fatal
San Juakien (sp?) Valley ,a disease limited to the valley. They won't
be willing to spend millions and years of development when there will be
no return on investment. They will stay with the large markets for cardiovasculars
and anti effectives.
Same old story, you get what you pay for.
|